Increased expression of HERG K⁺ channels contributes to myelodysplastic syndrome progression and displays correlation with prognosis stratification

References

• Shieh CC, Coghlan M, Sullivan JP, Gopalakrishnan M. Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol Rev. 2000;52:557–94.
   PubMed Web of Science ®Google Scholar
• Jehle J, Schweizer PA, Katus HA, Thomas D. Novel roles for hERG K(+) channels in cell proliferation and apoptosis. Cell Death Dis. 2001;2:e193. doi: 10.1038/cddis.2011.77
   Google Scholar
• Vandenberg JI, Perry MD, Perrin MJ, Mann SA, Ke Y, Hill AP. hERG K(+) channels: structure, function, and clinical significance. Physiol Rev. 2012;92:1393–478. doi: 10.1152/physrev.00036.2011
   PubMed Web of Science ®Google Scholar
• Sanguinetti MC, Tristani-Firouzi M. hERG potassium channels and cardiac arrhythmia. Nature. 2006;440:463–9. doi: 10.1038/nature04710
   PubMed Web of Science ®Google Scholar
• Wang Z. Roles of K+ channels in regulating tumor cell proliferation and apoptosis. Pflugers Arch. 2004;448:274–86. doi: 10.1007/s00424-004-1258-5
   PubMed Web of Science ®Google Scholar
• Pillozzi S, Brizzi MF, Balzi M, Crociani O, Cherubini A, Guasti L, et al. HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors. Leukemia. 2002;16:1791–8. doi: 10.1038/sj.leu.2402572
   PubMed Web of Science ®Google Scholar
• Pillozzi S, Brizzi MF, Bernabei PA, Bartolozzi B, Caporale R, Basile V, et al. VEGFR-1 (FLT-1), beta1 integrin, and hERG K+ channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome. Blood. 2007;110:1238–50. doi: 10.1182/blood-2006-02-003772
   PubMed Web of Science ®Google Scholar
• Pillozzi S, Masselli M, De Lorenzo E, Accordi B, Cilia E, Crociani O, et al. Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers. Blood. 2011;117:902–14. doi: 10.1182/blood-2010-01-262691
   PubMed Web of Science ®Google Scholar
• Corey SJ, Minden MD, Barber DL, Kantarjian H, Wang JC, Schimmer AD. Myelodysplastic syndromes: the complexity of stem-cell diseases. Nat Rev Cancer. 2007;7:118–29. doi: 10.1038/nrc2047
   PubMed Web of Science ®Google Scholar
• Pellagatti A, Boultwood J. The molecular pathogenesis of the myelodysplastic syndromes. Eur J Haematol. 2015;95:3–15.
   PubMed Web of Science ®Google Scholar
• Tefferi A, Vardiman JW. Myelodysplastic syndromes. N Engl J Med. 2009;361:1872–85. doi: 10.1056/NEJMra0902908
   PubMed Web of Science ®Google Scholar
• Pellagatti A, Cazzola M, Giagounidis A, Perry J, Malcovati L, Della Porta MG, et al. Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. Leukemia. 2010;24:756–64. doi: 10.1038/leu.2010.31
   PubMed Web of Science ®Google Scholar
• Raza A, Galili N. The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes. Nat Rev Cancer. 2012;12:849–59. doi: 10.1038/nrc3321
   PubMed Web of Science ®Google Scholar
• Tang G, DiNardo C, Zhang L, Ravandi F, Khoury JD, Huh YO, et al. MLL gene amplification in acute myeloid leukemia and myelodysplastic syndromes is associated with characteristic clinicopathological findings and TP53 gene mutation. Hum Pathol. 2015;46:65–73. doi: 10.1016/j.humpath.2014.09.008
   PubMed Web of Science ®Google Scholar
• Tao JL, Li LJ, Fu R, Wang HQ, Jiang HJ, Yue LZ, et al. Elevated TIM3+ hematopoietic stem cells in untreated myelodysplastic syndromes displayed aberrant differentiation, overproliferation and decreased apoptosis. Leuk Res. 2014;38:714–21. doi: 10.1016/j.leukres.2014.03.018
   PubMed Web of Science ®Google Scholar
• Xie W, Li X, Chen X, Huang S, Huang S. Decreased expression of PRDM2 (RIZ1) and its correlation with risk stratification in patients with myelodysplastic syndrome. Br J Haematol. 2010;150:242–4.
   PubMed Web of Science ®Google Scholar
• Li H, Liu L, Guo L, Zhang J, Du W, Li X, et al. HERG K+ channel expression in CD34+/CD38-/CD123(high) cells and primary leukemia cells and analysis of its regulation in leukemia cells. Int J Hematol. 2008;87:387–92. doi: 10.1007/s12185-008-0056-9
   PubMed Web of Science ®Google Scholar
• Zheng F, Li J, Du W, Wang N, Li H, Huang S. Human ether-a-go-go-related gen K+ channels regulate shedding of leukemia cell-derived microvesicles. Leuk Lymphoma. 2012;53:1592–8. doi: 10.3109/10428194.2012.661855
   PubMed Web of Science ®Google Scholar
• Li H, Du YM, Guo L, Jie S, Zhang S, Du W, et al. The role of hERG1 K+ channels and a functional link between hERG1 K+ channels and SDF-1 in acute leukemic cell migration. Exp Cell Res. 2009;315:2256–64. doi: 10.1016/j.yexcr.2009.04.017
   PubMed Web of Science ®Google Scholar
• Lastraioli E, Guasti L, Crociani O, Polvani S, Hofmann G, Witchel H, et al. herg1 gene and HERG1 protein are overexpressed in colorectal cancers and regulate cell invasion of tumor cells. Cancer Res. 2004;64:606–11. doi: 10.1158/0008-5472.CAN-03-2360
   PubMed Web of Science ®Google Scholar
• Ding XW, Luo HS, Luo B, Xu DQ, Gao S. Overexpression of hERG1 in resected esophageal squamous cell carcinomas: a marker for poor prognosis. J Surg Oncol. 2008;97:57–62. doi: 10.1002/jso.20891
   PubMed Web of Science ®Google Scholar
• Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105–11. doi: 10.1038/35102167
   PubMed Web of Science ®Google Scholar
• Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730–7. doi: 10.1038/nm0797-730
   PubMed Web of Science ®Google Scholar
• Greenberg PL, Young NS, Gattermann N. Myelodysplastic syndromes. Hematol Am Soc Hematol Educ Program. 2002:136–61.
   PubMedGoogle Scholar
• Wang H, Zhang Y, Cao L, Han H, Wang J, Yang B, et al. HERG K+ channel, a regulator of tumor cell apoptosis and proliferation. Cancer Res. 2002;62:4843–8.
   PubMed Web of Science ®Google Scholar
• Afrasiabi E, Hietamäki M, Viitanen T, Sukumaran P, Bergelin N, Törnquist K. Expression and significance of HERG (KCNH2) potassium channels in the regulation of MDA-MB-435S melanoma cell proliferation and migration. Cell Signal. 2010;22:57–64. doi: 10.1016/j.cellsig.2009.09.010
   PubMed Web of Science ®Google Scholar
• Crociani O, Guasti L, Balzi M, Becchetti A, Wanke E, Olivotto M, et al. Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor cells. J Biol Chem. 2003;278:2947–55. doi: 10.1074/jbc.M210789200
   PubMed Web of Science ®Google Scholar
• Patanѐ S. HERG-targeted therapy in both cancer and cardiovascular system with cardiovascular drugs. Int J Cardiol. 2014;176:1082–5. doi: 10.1016/j.ijcard.2014.07.129
   PubMed Web of Science ®Google Scholar